Multidisciplinary training in cardiovascular engineering

心血管工程多学科培训

• 批准号: 10208935
• 负责人: VICTOR H BAROCAS
• 金额: $ 25.91万
• 依托单位: UNIVERSITY OF MINNESOTA
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-07-01 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10208935
• 关键词: Cardiovascular system; Engineering; Training; multidisciplinary

Project Summary In spite of great effort and many medical advances, heart disease remains the leading cause of death in the United States causing 1 in 4 deaths annually. In 2010, the treatment of these diseases accounted for about $1 of every $6 spent on healthcare in the U.S. The demand for cardiovascular devices is only going to increase as the incidence of cardiovascular diseases rises, the population ages, and medical technology continues to advance. To help meet this demand, we need biomedical engineers with the appropriate advanced multidisciplinary education and training. The proposed T32 training program is designed uniquely to educate, train, and experientially sharpen doctoral students in biomedical engineering, within a multidisciplinary context that specifically engages clinicians and clinician-scientists towards that end. During their participation as trainees in their first two years of predoctoral study in the University of Minnesota (UMN)'s established biomedical engineering graduate program, six trainees per year will interact with a strong training faculty in numerous ways, including these distinctive activities beyond commencing their doctoral research: • complete the courses Advanced Cardiac Physiology and Anatomy (organized by the leader of UMN-Medtronic Visible Heart Lab collaboration) and Cardiovascular Devices (taught by local cardiovascular device company experts); • complete a clinical immersion in one of the UMN cardiovascular clinics; • attend an innovation lecture series (offered through the UMN Medical Devices Center); • attend monthly clinical focus lunches with invited clinicians presenting specific cardiovascular diseases and associated medical device limitations; and • attend monthly professional development lunches with invited speakers addressing broad career opportunities including medtech company R&D, FDA, and patent law. We will recruit a diverse group of trainees, and the program will be reviewed periodically by an advisory committee to ensure its success in all respects. We expect that the resulting multidisciplinary research and perspective of our trainees will enable them to meet the aforementioned demand by driving future technological advancements, either as R&D engineers at cardiovascular device companies, device regulators at federal labs, or as professors leading their own research programs in cardiovascular engineering.

项目摘要 尽管付出了巨大的努力和许多医学进步，心脏病仍然是 在美国死亡，每年造成四分之一的死亡。在2010年，这些处理 在美国，疾病约为每6美元用于医疗保健的$ 1 $ 1 随着心血管疾病的发病率，心血管设备只会增加 上升，人口年龄和医疗技术继续前进。帮助满足这个 需求，我们需要具有适当高级多学科的生物医学工程师 教育和培训。拟议的T32培训计划是针对教育的独特设计的 火车，并在生物医学工程领域熟练培训博士生 多学科的环境专门参与临床医生和临床科学家 结尾。在参加学员的头两年中，他们在参与期间 明尼苏达大学（UMN）成立的生物医学工程研究生课程，六个 每年学员将以多种方式与强大的培训教师互动，包括这些 除了开始博士研究之外的独特活动： •完成课程晚期心脏生理和解剖学（由 UMN-中间人可见的心脏实验室合作的负责人）和心血管设备 （由当地心血管设备公司专家教授）； •在UMN心血管诊所之一中完成临床浸入； •参加创新讲座系列（通过UMN医疗设备中心提供）； •与受邀临床医生一起参加每月临床重点午餐 心血管疾病和相关的医疗器械限制；和 •参加每月专业发展午餐，与受邀演讲者致辞 MedTech Company R＆D，FDA和专利法等广泛的职业机会。 我们将招募一个潜水员的学员，并将定期审查该计划 咨询委员会确保其在各个方面的成功。我们期望由此产生 多学科研究和我们培训的观点将使他们能够满足 通过推动未来的技术进步，可以通过研发来提高需求 心血管设备公司的工程师，联邦实验室的设备调节器或AS 教授领导自己的心血管工程研究计划。